35.33MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.14
Dividend Share
-
Dividend Yield
-
Earnings Share
-
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
157,220
Gross Profit TTM
48,952
EBITDA
-
Profit Margin
0.00%
Return On Assets TTM
-759.60%
Return On Equity TTM
-3956.02%
Revenue Per Share TTM
0.05
Qtly Revenue Growth YOY
662.70%
Diluted Eps TTM
0
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
0
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
321.05
3.56%264.48
1.62%90.54
1.12%158.51
0.32%612.14
0.11%282.85
-2.26%893.52
-0.60%19.06
-0.42%74.14
-0.04%444.93
-0.03%